FOSUN PHARMA(02196) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

HK Stock MarketDetailed Quotes

02196 FOSUN PHARMA

Watchlist

15.440
+0.340+2.25%

Market Closed Mar 28 16:08 CST

41.10BMarket Cap13.74P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

FOSUN PHARMA (02196) spent 4.9984 million yuan on March 28 to buy back 0.197 million shares of A-shares.
FOSUN PHARMA (02196) announced that the company will spend 4.9984 million yuan on March 28, 2025...
Zhitong FinanceMar 28 05:18 ET
FOSUN PHARMA (02196) has received a pledge of 30 million shares from its controlling Shareholder FOSUN High Technology.
FOSUN PHARMA (02196) released an announcement, Shanghai FOSUN PHARMA (Group) Co., Ltd. (hereinafter referred to as "the company..."
Zhitong FinanceMar 27 06:00 ET
FOSUN PHARMA (02196.HK) spent 15.005 million yuan to repurchase 0.6035 million A-shares on March 27.
On March 27, Gelonghui reported that FOSUN PHARMA (02196.HK) announced that on March 27, 2025, it spent 15.005 million yuan to repurchase 0.6035 million A-shares, with repurchase prices ranging from 24.75 to 25.03 yuan per share.
Gelonghui FinanceMar 27 05:28 ET
Domestic Innovative Drugs are once again surging towards overseas markets! Concept stocks have responded with a significant increase. Is the external authorization model the optimal choice?
① As of the time of publication, the Hang Seng Innovative Drugs Index has risen over 5%, with multiple Innovative Drugs concept stocks experiencing double-digit gains; ② In recent days, Jiangsu Hengrui Pharmaceuticals, Hepo Pharmaceutical, UNITED LAB, and other Biotech companies have issued announcements about "going abroad"; ③ Northeast Securities stated that top MNCs recognize the R&D capabilities of Chinese local companies and are more willing to assign high valuations.
cls.cnMar 27 04:08 ET
Is the profit turning point starting to appear? The Hong Kong stock market's Innovative Drugs Sector is strengthening, and the annual reports show that multiple pharmaceutical companies are entering a period of performance harvest.
① The Innovative Drugs Sector in Hong Kong stocks has risen across the board, what Bullish factors are worth paying attention to? ② Annual reports show that multiple pharmaceutical companies have entered a performance harvest period, does this indicate that a profit turning point is approaching?
cls.cnMar 27 03:32 ET
FOSUN PHARMA's net income returns to positive growth. Wu Yifang: Believes that CAR-T products will be included in Class B directory | Direct hit on the Earnings Conference.
① FOSUN PHARMA recovered nearly 3 billion yuan in funds in 2024 by selling its financial Assets, and will continue to strengthen the effort to recover funds this year; ② Wu Yifang believes that CAR-T products meet the positioning of high clinical value, exceeding the basic insurance coverage, and is confident that CAR-T will be included in Category C.
cls.cnMar 26 08:10 ET

Comments

Spinee

Jun 25, 2024 10:45

HSI Opens Up 60 pts; LI AUTO & NIO Advance, as HENLIUS Rockets 21%

Hong Kong stocks opened higher in the morning. $Hang Seng Index (800000.HK)$opened 60 points or 0.3% higher at 18,088. $Hang Seng China Enterprises Index (800100.HK)$ opened 22 points or 0.3% higher at 6,463. $Hang Seng TECH Index (800700.HK)$ opened 11 points or 0.3% higher at 3,689.
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...

Spinee

Apr 26, 2023 00:34

HSI Slides 342 Pts; Techs & Pharmas Gloom

$Hang Seng Index (800000.HK)$ concluded the day at 19,617, down 342 pts or 1.7%. $Hang Seng China Enterprises Index (800100.HK)$ sagged 131 pts or 2% to 6,601. $Hang Seng TECH Index (800700.HK)$ faded 137 pts or 3.5% to 3,824. The turnover aggregated $106.657 billion.
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...

Senorita Earnings

Mar 2, 2023 13:54

Columns Expert Meeting Minutes | Seven Development Trends of the China Medical Aesthetics Industry

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...

Spinee

Dec 14, 2022 14:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $FOSUN PHARMA (02196.HK)$ shares were opened 12% higher to 29 yuan.
$Pfizer (PFE.US)$ $AIM VACCINE (06660.HK)$

Spinee

Dec 7, 2022 11:36

In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:

First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates;
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...